East Asia & Pacific (excluding high income) vs Iran: Immunization, HepB3
East Asia & Pacific (excluding high income)
87.4%
in 2024
Iran
98.0%
in 2024
East Asia & Pacific (excluding high income) rank
16th
Iran rank
19th
Immunization, HepB3 over time
- East Asia & Pacific (excluding high income)
- Iran
How they compare
Iran currently reports 98.0% against 87.4% in East Asia & Pacific (excluding high income), a difference of 10.6%.
That makes Iran's figure about 1.1 times East Asia & Pacific (excluding high income)'s.
Across all 31 years both countries report, Iran has been ahead every year.
East Asia & Pacific (excluding high income) ranks 16th and Iran ranks 19th of 47 groups.
Iran has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | East Asia & Pacific (excluding high income) | Iran | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 16.5% | 81.2% | 64.6% | Iran |
| 2000s | 74.5% | 97.2% | 22.7% | Iran |
| 2010s | 93.7% | 98.8% | 5.1% | Iran |
| 2020s | 89.2% | 98.6% | 9.4% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, East Asia & Pacific (excluding high income) or Iran?
- Iran, at 98.0% against 87.4% in East Asia & Pacific (excluding high income) as of 2024.
- What is the difference in immunization, hepb3 between East Asia & Pacific (excluding high income) and Iran?
- 10.6%, with Iran ahead.
- How many years of comparable data are there for East Asia & Pacific (excluding high income) and Iran?
- 31 years are reported by both, from 1994 to 2024.
- How do East Asia & Pacific (excluding high income) and Iran rank globally for immunization, hepb3?
- East Asia & Pacific (excluding high income) ranks 16th and Iran ranks 19th of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.